Slc7a7−/− developed PAP in ~30% of the animals (i.e., 7 out of the 21 mice studied), a similar percentage as in LPI patients, which ranges from 10–60% in the different LPI cohorts [39,40]. Here, SLC7A7 is linked to lysinuric protein intolerance.